Exact Sciences announces financial results for the third quarter ended Sept. 30, 2009
Exact Sciences Corp. (Nasdaq: EXAS) today announced its financial results for the third quarter ended Sept. 30, 2009. Exact reported total revenues of $1.3 million for the third quarter of 2009, compared to total revenues of... [read full story]
|
RELATED
|
|
Exact Sciences pares its Q3 net losses
Exact Sciences, a colorectal cancer screening firm, is thriving after its move to Wisconsin, having swung from negative revenues a year ago to $1.3 million in third-quarter sales and paring its Q3 net losses by more than...
Exact Sciences posts narrower loss
Exact Sciences on Tuesday reported a net loss of $1 million, or 3 cents a share, for the third quarter that ended Sept. 30, narrower than the $3 million net loss, or 11 cents a share for the same period last year.
Exact Sciences Reports Third-Quarter 2009 Financial Results (Business Wire)
Exact reported total revenues of $1.3 million for the third quarter of 2009, compared to total revenues of ($663,000) during the same period of 2008. Total revenues increased due to the quarterly non-cash allocation that...
International Editions
English - US | English - UK | Deutsch | Français | Español - España | Português - Portugal | Italiano | Čeština | Русский (Russian) | عربي (Arabic) | 中文（简）(Simplified Chinese) | Español - México | Português - Brasil | 한국어 (Korean) | English - India
